Coronavirus vaccines get a biotech boost.

Dance, Amber

Dance, Amber.

Nature ; 583(7817): 647-649, 2020 07.

Article in English | MEDLINE | ID: covidwho-824096

Subject(s)

Betacoronavirus/immunology; Coronavirus Infections; Drug Development; Pandemics; Pneumonia, Viral; Viral Vaccines; Antibodies, Neutralizing/immunology; Antibodies, Viral/immunology; COVID-19; COVID-19 Vaccines; Clinical Trials as Topic; Coronavirus Infections/economics; Coronavirus Infections/epidemiology; Coronavirus Infections/immunology; Coronavirus Infections/prevention & control; Coronavirus Infections/virology; Humans; Pandemics/prevention & control; Pneumonia, Viral/epidemiology; Pneumonia, Viral/immunology; Pneumonia, Viral/prevention & control; Pneumonia, Viral/virology; Respiratory Syncytial Viruses/immunology; SARS-CoV-2; Spike Glycoprotein, Coronavirus/immunology; T-Lymphocytes/immunology; Viral Vaccines/chemistry; Viral Vaccines/economics; Viral Vaccines/immunology; Viral Vaccines/supply & distribution

Keywords

Diseases; Immunology; SARS-CoV-2; Vaccines

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Viral Vaccines / Coronavirus Infections / Pandemics / Betacoronavirus / Drug Development Type of study: Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: Nature Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google